Karvy Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.50 Cr
- Company Age 35 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.38 Cr
- Satisfied Charges ₹ 23.17 Cr
- Revenue Growth -19.31%
- Profit Growth -72.79%
- Ebitda -39.35%
- Net Worth 7.94%
- Total Assets 14.47%
About Karvy Therapeutics
Karvy Therapeutics Pvt Ltd (KTPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 February 1989 and has a history of 35 years and 11 months. Its registered office is in Haripar Pal, Gujarat, India.
The Corporate was formerly known as Charmy Therapeutics And Chemicals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹20.38 Cr. The company has closed loans amounting to ₹23.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jagdish Kothari, Parag Kothari, and Shilpa Kothari serve as directors at the Company.
Company Details
- Location
Haripar Pal, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1989PTC011930
- Company No.
011930
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Karvy Therapeutics Pvt Ltd offer?
Karvy Therapeutics Pvt Ltd offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate, Chemical Reagents & Catalysts, Fatty Esters, Insecticides and Pesticides, Pesticide Intermediate, Industrial Chemicals & Supplies, Aldehydes, Industrial Chemicals, Agro Intermediates.
Who are the key members and board of directors at Karvy Therapeutics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdish Kothari  | Director | 10-Oct-2002 | Current |
| Parag Kothari | Director | 24-Feb-1989 | Current |
| Shilpa Kothari | Director | 30-Mar-2007 | Current |
Financial Performance of Karvy Therapeutics.
Karvy Therapeutics Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.31% decrease. The company also saw a substantial fall in profitability, with a 72.79% decrease in profit. The company's net worth moved up by a moderate rise of 7.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Karvy Therapeutics?
In 2023, Karvy Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Proveca International Limited Liability PartnershipShilpa Kothari is a mutual person
Charges (Loans)
₹20.38 Cr
₹23.17 Cr
Charges Breakdown by Lending Institutions
- Others : 19.88 Cr
- Hdfc Bank Limited : 0.51 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Oct 2022 | Hdfc Bank Limited | ₹1.03 M | Open |
| 25 Nov 2021 | Hdfc Bank Limited | ₹2.16 M | Open |
| 15 Nov 2021 | Hdfc Bank Limited | ₹1.86 M | Open |
| 14 Jun 2017 | Others | ₹19.88 Cr | Open |
| 05 Dec 2012 | Bank Of India | ₹9.80 Cr | Satisfied |
How Many Employees Work at Karvy Therapeutics?
Karvy Therapeutics has a workforce of 11 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Karvy Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karvy Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.